arrow
Return

High-flow nasal Oxygen with or without alternating helmet Non-invasive ventilation for Oxygenation sUpport in acute Respiratory failure (HONOUR): a protocol for a pilot randomised controlled trial

delete2025-10-27
delete0
delete
OA
AI
F
Federico Angriman
B
Bruno L. Ferreyro *
P
Papadakis, Marios
M
Michael C. Sklar
N
Neill K. J. Adhikari
S
Sean M. Bagshaw
L
Laurent Brochard
B
Brian H. Cuthbertson
L
Lorenzo Del Sorbo
R
Robert Fowler
A
Anna Geagea
G
Granton, John T.
S
Sangeeta Mehta
L
Laveena Munshi
J
John Muscedere
J
Julie Nardi
K
Ken Kuljit S. Parhar
R
Ruxandra Pinto
D
Dominique Piquette
J
Julie Hallet
K
Krausz, Mate
S
Siobhan Tobin
D
Damon C. Scales
N
Niall D. Ferguson
DOI:10.1136/bmjopen-2025-111526delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Introduction Acute hypoxaemic respiratory failure is a common reason for intensive care unit (ICU) admission. Non-invasive respiratory support strategies such as high-flow nasal oxygen (HFNO) and helmet non-invasive ventilation may reduce the need for invasive mechanical ventilation and death. The High-flow nasal Oxygen with or without alternating helmet Non-invasive ventilation for Oxygenation sUpport in acute Respiratory failure pilot trial is designed to compare helmet non-invasive ventilation combined with HFNO vs HFNO alone in patients with acute hypoxaemic respiratory failure and to determine the feasibility of a larger randomised controlled trial.Methods and analysis This is a pragmatic, open-label, multicentre randomised controlled pilot trial enrolling 200 critically ill adults with acute hypoxaemic respiratory failure across 12 Canadian ICUs. Participants are randomised 1 to 1 to receive either helmet non-invasive ventilation plus HFNO or HFNO alone for at least 48 hours. The primary aim is to assess feasibility metrics including recruitment rate, protocol adherence and fidelity to pre-specified intubation criteria. Secondary outcomes include rates of intubation, all-cause mortality, ventilator-free days, ICU length of stay and quality of life at 6 months. Primary and secondary outcomes will be analysed using Bayesian methods.Ethics and dissemination Ethics approval has been obtained at all participating centres. Findings will inform the feasibility and design of a future full-scale trial and be disseminated through peer review publications and conference presentations.Trial registration number ClinicalTrials.gov Identifier: NCT05078034.
Keywords:
Respiratory Distress Syndrome
Ventilators, Mechanical
Oxygen Saturation
Hypoxia

Journal

BMJ Open cover
BMJ Open
IF:
2.3
Papers:
2.9K
Citations:
9.2W

Organization

U
university health network toronto
Scholars:
1.7W
Papers: 1.4W
Citations: 19
S
sinai health system toronto
Scholars:
5.1K
Papers: 4.1K
Citations: 1
U
University of Alberta
Scholars:
1.1K
Papers: 520
Citations: 1
S
sunnybrook health science center
Scholars:
5.9K
Papers: 5.0K
Citations: 3
S
saint michaels hospital toronto
Scholars:
5.9K
Papers: 5.0K
Citations: 12
U
university of toronto
Scholars:
14.5W
Papers: 11.9W
Citations: 165
researcher View more organizations